Results 171 to 180 of about 105,651 (291)

Insecticide resistance in Aedes aegypti and Aedes albopictus in southern Benin: quantification, investigation of kdr mutations, and detection of detoxification enzyme activity. [PDF]

Trop Med Health
Konkon AK, Aikpon R, Hoyochi I, Zoungbédji DM, Sovi A, Salako AS, Konkon C, Dangnon B, Yahoue G, Adjovi RV, Antoine L, Ahouandjinou J, Grace NK, Adjottin B, Baba-Moussa L, Osse R, Akogbéto M, Padonou GG.   +17 more
europepmc   +1 more source

ESG Decoupling Phenomenon: A Systematic and Bibliometric Analysis

Business Strategy and the Environment, EarlyView.
ABSTRACT ESG decoupling, defined as the gap between a firm's ESG disclosures and its actual practices, poses a critical challenge to corporate sustainability. Using the PRISMA protocol, 451 articles were selected for a comprehensive bibliometric and systematic literature review to map the intellectual structure and thematic evolution of the research on
Maryam Laeeq, Farida Akhtar, Han Lin Shang   +2 more
wiley   +1 more source

Barriers and opportunities in developing community-based maternal and child health surveillance: A mixed methods study in Depok, Indonesia. [PDF]

PLoS One
Sigit FS, Yelda F, Ayuningtyas D, Adisasmita AC, Prasetyo S.   +4 more
europepmc   +1 more source

Green Hydrogen for Public Transportation: Insights From an ABM and From Palma de Mallorca Case Study

Business Strategy and the Environment, EarlyView.
ABSTRACT The development of green hydrogen (GH2) value chains is crucial for decarbonizing sectors such as transport and industry. Their emergence, however, requires coordination among diverse actors, technologies, and regulations, which traditional analytical approaches struggle to capture.
Roberta De Cristofaro, Cristina Ponsiglione, Simonetta Primario   +2 more
wiley   +1 more source

A Critical Analysis of Microsoft's Rhetoric and Reality of Sustainability Engagement

Business Strategy and the Environment, EarlyView.
ABSTRACT This study critically examines Microsoft's environmental, social and governance (ESG) rhetoric and operational reality, to offer insights that extend beyond conventional greenwashing or bluewashing. Drawing on over 20 years of Microsoft's sustainability reports (2003–2024), third‐party ESG evaluations and media investigations, it employs ...
Omaima A. G. Hassan, Iqbal Khadaroo
wiley   +1 more source

A simple <i>ex vivo</i> bladder infection model permits study of host-pathogen interactions in urinary tract infection. [PDF]

FEMS Microbes
Köhn RM, Ramirez Finn L, Durand M, Costas A, Söderström B, Lacerda Mariano L, Ingersoll MA.   +6 more
europepmc   +1 more source

Revisiting the synthesis of dimethyl carbonate from methanol and carbon dioxide

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract The process for producing dimethyl carbonate (DMC) from carbon dioxide (CO2) and methanol is explored in this article. It provides an overview of the thermodynamics involved in DMC synthesis, discussing the challenges and potential solutions. The article highlights the reported use of catalysts and dehydrating agents to improve DMC yield and ...
Diego Alexander Santos Araque, Niloofar Mozaffari, Louis Fradette, Serge Kaliaguine   +3 more
wiley   +1 more source

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing

Clinical Pharmacology &Therapeutics, EarlyView.
Model‐informed drug development is increasingly integrated across the drug development continuum, enabling more efficient, cost‐effective, and targeted trials while reducing reliance on animal studies. Achieving pharmacoequity requires not only equitable access to medicines but also to the data and knowledge that inform drug development and regulatory ...
Shakir Atoyebi, Prajith Venkatasubramanian, Abdulafeez Akinloye, Oluwasegun Eniayewu, Brookie M. Best, Laura Else, Adeniyi Olagunju   +6 more
wiley   +1 more source

Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network

Clinical Pharmacology &Therapeutics, EarlyView.
ASCPT has a mission to advance clinical pharmacology and translational sciences to reduce health disparities. The development, regulatory, and outcomes (DRO) network within ASCPT strives to advance pharmacoequity globally. Pharmacoequity, coined by Utibe Essien (2021), is the principle that all individuals, regardless of race, ethnicity, geography, or ...
Priya Jayachandran, Mayur K. Ladumor, Georgios Vlasakakis, Andrew Riselli, Katarina V. Ilic, Rob C. van Wijk, Mohamed Elmeliegy, Jatinder Kaur Mukker, Aarti Sawant‐Basak, Tao Long, Juyao Dong, Noha Rayad, Tao Zhang, on behalf of the DRO Network   +13 more
wiley   +1 more source

Farnesol, the farnesol pathway, and the immune-gut-brain axis. [PDF]

Front Pharmacol
Gates M, Schumacher SM, Doyle WJ, Sofaly N, Roullet JB, Ochoa-Repáraz J.   +5 more
europepmc   +1 more source